CGBIO launches ‘MEDICLORE’, an anti-adhesion agent in Indonesia DATE 2022-06-07 VIEWSViews : 3,489 views
CGBIO cooperates with US WFIRM to conduct bone and cartilage regeneration research using 3D printing DATE 2022-05-12 VIEWSViews : 1,541 views
CGBIO Reached 94.6 Billion Won in Sales in 2021 Sales Up 133% Over 5 Years, Rapid Operating Profits Increase by 471% DATE 2022-04-13 VIEWSViews : 2,123 views
CGbio and Kerunxi Medical of China sign 10 billion KRW contract for export of Bongros dental bone graft material DATE 2022-03-23 VIEWSViews : 2,949 views
CGBIO signed an export contract worth KRW 100 billion for “BONGROS”, a bone replacement material with Shanghai Sanyou Medical DATE 2022-03-04 VIEWSViews : 2,974 views
CGBIO established a corporation in Indonesia and entered the Southeast Asian aesthetic surgery market DATE 2022-03-04 VIEWSViews : 3,074 views
Renewed Version of a Wound Therapeutic Instrument exploiting negative pressure, the ‘CURAVAC’, attained an Approval in China DATE 2022-03-02 VIEWSViews : 2,086 views
BELUNA, the Bread Massaging Instrument of CGBIO, attained the Certification of Medical Instrument… Propagation of the ‘Solution for Natural Breast’ is expectedly promoted… DATE 2022-03-02 VIEWSViews : 1,738 views
CGBIO obtains approval for next-generation ceramic cage ‘NOVOMAX Fusion’ in Australia DATE 2021-11-11 VIEWSViews : 1,532 views
CGBIO gets green light in Mexico for BMP-2 bone graft NOVOSIS DATE 2021-09-29 VIEWSViews : 2,112 views